Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome. Steg PG, Szarek M, Valgimigli M, Islam S, et al. Can J Cardiol 2023;39:1315-1324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Steg PG, Szarek M, Valgimigli M, Islam S, et al. Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome. Can J Cardiol 2023;39:1315-1324.
PMID: 37116789